Miralles GD - Search Results

1

Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.

Eron JJ, Gulick RM, Bartlett JA, Merigan T, Arduino R, Kilby JM, Yangco B, Diers A, Drobnes C, DeMasi R, Greenberg M, Melby T, Raskino C, Rusnak P, Zhang Y, Spence R, Miralles GD. Eron JJ, et al. Among authors: miralles gd. J Infect Dis. 2004 Mar 15;189(6):1075-83. doi: 10.1086/381707. Epub 2004 Mar 2. J Infect Dis. 2004. PMID: 14999611 Clinical Trial.

2

Evolution of genotypic and phenotypic resistance during chronic treatment with the fusion inhibitor T-1249.

Melby T, Demasi R, Cammack N, Miralles GD, Greenberg ML. Melby T, et al. Among authors: miralles gd. AIDS Res Hum Retroviruses. 2007 Nov;23(11):1366-73. doi: 10.1089/aid.2006.0277. AIDS Res Hum Retroviruses. 2007. PMID: 18184079

3

T-1249 retains potent antiretroviral activity in patients who had experienced virological failure while on an enfuvirtide-containing treatment regimen.

Lalezari JP, Bellos NC, Sathasivam K, Richmond GJ, Cohen CJ, Myers RA Jr, Henry DH, Raskino C, Melby T, Murchison H, Zhang Y, Spence R, Greenberg ML, Demasi RA, Miralles GD; T1249-102 Study Group. Lalezari JP, et al. Among authors: miralles gd. J Infect Dis. 2005 Apr 1;191(7):1155-63. doi: 10.1086/427993. Epub 2005 Feb 22. J Infect Dis. 2005. PMID: 15747252 Clinical Trial.

4

Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons.

Bartlett JA, Miralles GD, Sevin AD, Silberman M, Pruitt SK, Ottinger J, Gryszowska V, Fiscus SA, Bucy RP; ACTG 380 Study Team. Bartlett JA, et al. Among authors: miralles gd. AIDS Res Hum Retroviruses. 2002 May 20;18(8):535-43. doi: 10.1089/088922202753747888. AIDS Res Hum Retroviruses. 2002. PMID: 12036483 Clinical Trial.

5

Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy.

Derdeyn CA, Kilby JM, Miralles GD, Li LF, Sfakianos G, Saag MS, Hockett RD, Bucy RP. Derdeyn CA, et al. Among authors: miralles gd. J Infect Dis. 1999 Dec;180(6):1851-62. doi: 10.1086/315117. J Infect Dis. 1999. PMID: 10558941

6

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.

Montefiori DC, Pantaleo G, Fink LM, Zhou JT, Zhou JY, Bilska M, Miralles GD, Fauci AS. Montefiori DC, et al. Among authors: miralles gd. J Infect Dis. 1996 Jan;173(1):60-7. doi: 10.1093/infdis/173.1.60. J Infect Dis. 1996. PMID: 8537683

7

Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection.

Alexander TH, Ortiz GM, Wellons MF, Allen A, Grace EJ 2nd, Schweighardt B, Brancato J, Sandberg JK, Furlan SN, Miralles GD, Nixon DF, Bartlett JA. Alexander TH, et al. Among authors: miralles gd. J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):475-81. doi: 10.1097/00126334-200312150-00005. J Acquir Immune Defic Syndr. 2003. PMID: 14657757

8

Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.

Schweighardt B, Ortiz GM, Grant RM, Wellons M, Miralles GD, Kostrikis LG, Bartlett JA, Nixon DF. Schweighardt B, et al. Among authors: miralles gd. AIDS. 2002 Nov 22;16(17):2342-4. doi: 10.1097/00002030-200211220-00018. AIDS. 2002. PMID: 12441810

9

Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.

Ortiz GM, Wellons M, Brancato J, Vo HT, Zinn RL, Clarkson DE, Van Loon K, Bonhoeffer S, Miralles GD, Montefiori D, Bartlett JA, Nixon DF. Ortiz GM, et al. Among authors: miralles gd. Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13288-93. doi: 10.1073/pnas.221452198. Epub 2001 Oct 30. Proc Natl Acad Sci U S A. 2001. PMID: 11687611 Free PMC article. Clinical Trial.

10

Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjects.

Thompson M, DeJesus E, Richmond G, Wheeler D, Flaherty J, Piliero P, True A, Chiu YY, Zhang Y, McFalls E, Miralles GD, Patel IH. Thompson M, et al. Among authors: miralles gd. AIDS. 2006 Feb 14;20(3):397-404. doi: 10.1097/01.aids.0000200534.94608.7d. AIDS. 2006. PMID: 16439873 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters